EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

m6A readers, writers, erasers, and the m6A epitranscriptome in breast cancer

Belinda J Petri, Carolyn M Klinge iD

Journal of Molecular Endocrinology · 01.02.2023 · 70 (2)

DOI: 10.1530/jme-22-0110 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Molecular Endocrinology, erschienen am 01.02.2023. Verfasst von Belinda J Petri und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry & Molecular Genetics, University of Louisville School of Medicine, Louisville, Kentucky, USA. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 293 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIEHS NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epitranscriptomic modification of RNA regulates human development, health, and disease. The true diversity of the transcriptome in breast cancer including chemical modification of transcribed RNA (epitranscriptomics) is not well understood due to limitations of technology and bioinformatic analysis. N-6-methyladenosine (m6A) is the most abundant epitranscriptomic modification of mRNA and regulates splicing, stability, translation, and intracellular localization of transcripts depending on m6A association with reader RNA-binding proteins. m6A methylation is catalyzed by the METTL3 complex and removed by specific m6A demethylase ALKBH5, with the role of FTO as an ‘eraser’ uncertain. In this review, we provide an overview of epitranscriptomics related to mRNA and focus on m6A in mRNA and its detection. We summarize current knowledge on altered levels of writers, readers, and erasers of m6A and their roles in breast cancer and their association with prognosis. We summarize studies identifying m6A peaks and sites in genes in breast cancer cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansFemaleRNAMethylationRNA, MessengerRNA-Binding ProteinsAdenosineMethyltransferasesAlpha-Ketoglutarate-Dependent Dioxygenase FTO

Stichwörter der Autor:innen

breast cancerepitranscriptomem6AmRNA

Substanzen

RNARNA, MessengerRNA-Binding ProteinsAdenosineMETTL3 protein, humanMethyltransferasesFTO protein, humanAlpha-Ketoglutarate-Dependent Dioxygenase FTO

Autor:innen und Institutionen

  • Department of Biochemistry & Molecular Genetics, University of Louisville School of Medicine, Louisville, Kentucky, USA.
  • University of Louisville Center for Integrative Environmental Health Sciences (CIEHS), Louisvillle, Kentucky, USA.

ORCID-Profile: Carolyn M Klinge

Förderung

  • NIEHS NIH HHS
  • NCI NIH HHS

Zitieren

APA

Petri, B. J., & Klinge, C. M. (2023). m6A readers, writers, erasers, and the m6A epitranscriptome in breast cancer. Journal of Molecular Endocrinology, 70(2). https://doi.org/10.1530/jme-22-0110

Vancouver

Petri BJ, Klinge CM. m6A readers, writers, erasers, and the m6A epitranscriptome in breast cancer. Journal of Molecular Endocrinology. 2023;70(2). doi:10.1530/jme-22-0110

BibTeX
@article{Petri2023,
  author = {Petri, Belinda J and Klinge, Carolyn M},
  title = {m6A readers, writers, erasers, and the m6A epitranscriptome in breast cancer},
  journal = {Journal of Molecular Endocrinology},
  year = {2023},
  volume = {70},
  number = {2},
  doi = {10.1530/jme-22-0110}
}
Kostenlos starten →